Mirae Asset Global Etfs Holdings Ltd. Immunome Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Immunome Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 4,369 shares of IMNM stock, worth $56,709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,369Holding current value
$56,709% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
122Shares Held
43.8MCall Options Held
67.2KPut Options Held
65.9K-
Redmile Group, LLC San Francisco, CA4.89MShares$63.5 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$50.4 Million1.66% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$50.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$48.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.16MShares$41.1 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $157M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...